These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 19362962

  • 41. Progression from Monoclonal gammopathy of undetermined significance of the immunoglobulin M class (IgM-MGUS) to Waldenstrom Macroglobulinemia is associated with an alteration in lipid metabolism.
    Jalali S, Shi J, Ahsan N, Wellik L, Serres M, Buko A, Paludo J, Kim H, Tang X, Yang ZZ, Novak A, Kyle R, Ansell S.
    Redox Biol; 2021 May; 41():101927. PubMed ID: 33690107
    [Abstract] [Full Text] [Related]

  • 42. Asymptomatic Waldenstrom's macroglobulinemia.
    Alexanian R, Weber D, Delasalle K, Cabanillas F, Dimopoulos M.
    Semin Oncol; 2003 Apr; 30(2):206-10. PubMed ID: 12720137
    [Abstract] [Full Text] [Related]

  • 43. Familial Waldenstrom's macroglobulinemia.
    McMaster ML.
    Semin Oncol; 2003 Apr; 30(2):146-52. PubMed ID: 12720125
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia.
    Dogliotti I, Jiménez C, Varettoni M, Talaulikar D, Bagratuni T, Ferrante M, Pérez J, Drandi D, Puig N, Gilestro M, García-Álvarez M, Owen R, Jurczak W, Tedeschi A, Leblond V, Kastritis E, Kersten MJ, D'Sa S, Kaščák M, Willenbacher W, Roccaro AM, Poulain S, Morel P, Kyriakou C, Fend F, Vos JMI, Dimopoulos MA, Buske C, Ferrero S, García-Sanz R.
    Leukemia; 2023 Feb; 37(2):388-395. PubMed ID: 36435884
    [Abstract] [Full Text] [Related]

  • 46. A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders.
    Varettoni M, Zibellini S, Boveri E, Klersy C, Candido C, Rattotti S, Ferretti VV, Defrancesco I, Mangiacavalli S, Nizzoli ME, Flospergher E, Zerbi C, Bergamini F, Benvenuti P, Brociner M, Merati G, Paulli M, Arcaini L.
    Br J Haematol; 2019 Nov; 187(4):441-446. PubMed ID: 31276195
    [Abstract] [Full Text] [Related]

  • 47. Fifty-Year Incidence of Waldenström Macroglobulinemia in Olmsted County, Minnesota, From 1961 Through 2010: A Population-Based Study With Complete Case Capture and Hematopathologic Review.
    Kyle RA, Larson DR, McPhail ED, Therneau TM, Dispenzieri A, Kumar S, Kapoor P, Cerhan JR, Rajkumar SV.
    Mayo Clin Proc; 2018 Jun; 93(6):739-746. PubMed ID: 29656787
    [Abstract] [Full Text] [Related]

  • 48. Monoclonal gammopathy of undetermined significance.
    Kyle RA.
    Blood Rev; 1994 Sep; 8(3):135-41. PubMed ID: 7819815
    [Abstract] [Full Text] [Related]

  • 49. The spectrum of IgM monoclonal gammopathy in 430 cases.
    Kyle RA, Garton JP.
    Mayo Clin Proc; 1987 Aug; 62(8):719-31. PubMed ID: 3110508
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Prevalence of hepatitis C virus infection in IgM-type monoclonal gammopathy of uncertain significance and Waldenström macroglobulinemia.
    Veneri D, Aqel H, Franchini M, Meneghini V, Krampera M.
    Am J Hematol; 2004 Dec; 77(4):421. PubMed ID: 15551289
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Prognostic factors and indications for treatment of Waldenström's Macroglobulinemia.
    Kyle RA, Ansell SM, Kapoor P.
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):179-186. PubMed ID: 27825464
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in southeastern Netherlands.
    van de Poel MH, Coebergh JW, Hillen HF.
    Br J Haematol; 1995 Sep; 91(1):121-5. PubMed ID: 7577618
    [Abstract] [Full Text] [Related]

  • 58. Serum markers in the differential diagnosis of Waldenstrom macroglobulinemia and other IgM monoclonal gammopathies.
    Zou H, Yang R, Liao ZX, Qin TD, Chen P, Zhang BY, Cao YP, Huang HF.
    J Clin Lab Anal; 2019 Mar; 33(3):e22827. PubMed ID: 30485557
    [Abstract] [Full Text] [Related]

  • 59. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
    Basu D, Pathak D, Shyambabu C, Koner BC, Swaminathan RP.
    Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380
    [Abstract] [Full Text] [Related]

  • 60. Long-term evaluation of three multiple-case Waldenstrom macroglobulinemia families.
    McMaster ML, Csako G, Giambarresi TR, Vasquez L, Berg M, Saddlemire S, Hulley B, Tucker MA.
    Clin Cancer Res; 2007 Sep 01; 13(17):5063-9. PubMed ID: 17785558
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.